key: cord-1028979-ee71hggp
authors: Bwire, George M.; Majigo, Mtebe V.; Njiro, Belinda J.; Mawazo, Akili
title: Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis
date: 2020-08-02
journal: J Med Virol
DOI: 10.1002/jmv.26349
sha: a09698649d70bd37e5715a1e20e3441b30b6a933
doc_id: 1028979
cord_uid: ee71hggp

Testing is one of the commendable measures for curbing the spread of coronavirus disease (COVID‐19). But, it should be done using the most appropriate specimen and an accurate diagnostic test such as real‐time reverse transcription‐polymerase chain reaction (qRT‐PCR). Therefore, a systematic review was conducted to determine the positive detection rate of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in different clinical specimens using qRT‐PCR. A total of 8136 pooled clinical specimens were analyzed to detect SARS‐CoV‐2, the majority were nasopharyngeal swabs (69.6%). A lower respiratory tract (LRT) specimens had a positive rate (PR) of 71.3% (95% confidence interval [CI]: 60.3%‐82.3%) while no virus was detected in the urinogenital specimens. Bronchoalveolar lavage fluid (BLF) specimen had the PR of 91.8% (95% CI: 79.9%‐103.7%), followed by rectal swabs; 87.8% (95% CI: 78.6%‐96.9%) then sputum; 68.1% (95% CI: 56.9%‐79.4%). A low PR was observed in oropharyngeal swabs; 7.6% (95% CI: 5.7%‐9.6%) and blood samples; 1.0% (95% CI: −0.1%‐2.1%) whereas no SARS‐CoV‐2 was detected in urine samples. Feces had a PR of 32.8% (95% CI:1 5.8%‐49.8%). Nasopharyngeal swab, a widely used specimen had a PR of 45.5% (95% CI: 31.2%‐59.7%). In this study, SARS‐CoV‐2 was highly detected in LRT specimens while no virus was detected in urinogenital specimens. BLF had the highest PR followed by rectal swab then sputum. Nasopharyngeal swab which is widely used had moderate PR. Low PR was recorded in oropharyngeal swab and blood samples while no virus was found in urine samples. Last, the virus was detected in feces, suggesting SARS‐CoV‐2 transmission by the fecal route.

the positive detection rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different clinical specimens using qRT-PCR. A total of 8136 pooled clinical specimens were analyzed to detect SARS-CoV-2, the majority were nasopharyngeal swabs (69.6%). A lower respiratory tract (LRT) specimens had a positive rate (PR) of 71.3% (95% confidence interval [CI]: 60.3%-82.3%) while no virus was detected in the urinogenital specimens. Bronchoalveolar lavage fluid (BLF) specimen had the PR of 91.8% (95% CI: 79.9%-103.7%), followed by rectal swabs; 87.8% (95% CI: 78.6%-96.9%) then sputum; 68.1% (95% CI: 56.9%-79.4%). A low PR was observed in oropharyngeal swabs; 7.6% (95% CI: 5.7%-9.6%) and blood samples; 1.0% (95% CI: −0.1%-2.1%) whereas no SARS-CoV-2 was detected in urine samples. Feces had a PR of 32.8% (95% CI:1 5.8%-49.8%). Nasopharyngeal swab, a widely used specimen had a PR of 45.5% (95% CI: 31.2%-59.7%). In this study, SARS-CoV-2 was highly detected in LRT specimens while no virus was detected in urinogenital specimens. BLF had the highest PR followed by rectal swab then sputum. Nasopharyngeal swab which is widely used had moderate PR. Low PR was recorded in oropharyngeal swab and blood samples while no virus was found in urine samples. Last, the virus was detected in feces, suggesting SARS-CoV-2 transmission by the fecal route. However, there are reports of SARS-CoV-2 detections from other sites including feces, 6, 7 and, therefore, extending the spectrum of specimens other than those from respiratory tract to be considered for clinical diagnosis of SARS-CoV-2. From the beginning, health authorities, that is, World Health Organization (WHO) 8 and Centre for Disease Control and Prevention (CDC) advocated massive and rapid testing of COVID-19. Testing as one of commendable approaches in the fight against COVID-19 pandemic needs to be done using both most appropriate specimen 6 and an accurate diagnostic test like PCR. 9 If testing is properly done especially during this time when the reopening is on its way in most of the countries, the risk of SARS-CoV-2 transmission will be minimized.

Currently, the detection profile of SARS-CoV-2 RNA from different clinical specimens using qRT-PCR after onset of symptoms is not yet well established. A recent study by Wang et al 6 using 1070 clinical specimens such as bronchoalveolar lavage fluid (BLF), fibrobronchoscope brush biopsy (FBB), sputum, nasal and pharyngeal swabs, urine, feces, and blood collected from 205 patients revealed a dynamic profile with a high detection rate of virus from lower respiratory tract (LRT) specimens, that is, BLF and zero detection from urogenital tract specimen, that is, urine.

Therefore, the aim of this systematic review was to establish the profile of detecting SARS-CoV-2 from different types clinical specimens using a standard diagnostic test (qRT-PCR).

A systematic review protocol was developed based on the question "What is the positivity rate for detecting SARS-CoV-2 using qRT-PCR in different types of clinical specimens?". The review was developed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) guidelines. 10 The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO database: https://www.crd.york.ac. uk/PROSPERO with a registration number CRD42020189107). inclusion. The strategy was primarily developed for PubMed using keywords (Supporting Information Additional File S1). The search terms were combined using Boolean logic "OR" for synonymous terms and "AND" across elements of PCO (population, comparability, and outcome). Filters were set to exclude nonhuman studies, limit the publication period exclude review, and case report articles, among others. Keywords such as "laboratory diagnosis," "polymerase chain reaction," "clinical For inclusion in the final analysis, at least two simultaneously tested samples were required to be reported per study.

Study selection was managed using EndNote software version X7 (Thomson Reuters, 2015) where two independent reviewers (GMB and BJN) evaluated articles for potential inclusion by screening titles and abstracts followed by full-text screening to determine eligibility for final inclusion. Discrepancies were resolved by consensus, and/or consulting a third reviewer where necessary. Data extracted from study documents, included author's information,

year of publication, study design, and positivity rate (positive tests/total specimens) (Table 1 ). Unavailable, unclear information and additional details were requested from the corresponding author. In some of the studies, 7,13,14 patient was regarded as positive, if one of the specimens tested positive. Additionally, at least two specimens reported per test qualified for analysis where a positive patient was considered when one of the specimens tested positive, and recovered patient was considered when at least two qRT-PCR consecutive tests tested negative in all tested specimen.

The number of laboratory tests was counted based on the specimen tested not the number of patients.

DerSimonian-Laird (DL) random-effects analysis was performed to establish a summary estimate (positivity rate/proportion) by a randomeffects model using Open Meta Analyst software 17 

Output generated by Open Meta Analyst software through a cumulative forest plot was indirectly employed to assess the publication bias. 18 As such, the estimate of the proportions decreased with the increase in sample size. This decrease could be due to publication bias or it could be due to small-study effects. However, when the analysis was limited to study with at least 100 sample size, the overall positive detection rate would have been 34.6% (95% CI:

17.9%-51.3%) while that with all studies included regardless of the sample size was 42.7% (95% CI: 32.2%-53.3%) (Supporting Information Additional File S2). On the other hand, the quality of the included studies (risk of bias) was assessed using the Newcastle Ottawa Scale adapted for cross-sectional studies (Supporting Information Additional File S3) as previously described elsewhere. 19 The risk of bias was evaluated by two independent reviewers (GMB and BJN). Discrepancies were resolved by consensus, and/or consulting a third reviewer (MVM) where necessary.

Of 780 pooled studies, seven studies qualified for final analysis (Table 1) . Among the seven articles, information reported on positive detection rate was extracted from four studies 5,6,15,16 for suspected cases, while in three studies 7,13,14 information was recorded if at least one specimen tested positive (confirmed cases) from the simultaneously tested specimens and the recording of positive tests were stopped when at least two consecutive qTR-PCR tested negative in all specimens. 7,13 Different types of clinical specimens were tested for SARS-CoV-2, BLF, 5,6 FBB, 6 sputum. [5] [6] [7] 14, 15, 16 Some of the studies reported pharyngeal specimen without specifying whether the route was nasal of oral. 6, 7 One study reported nasal and pharyngeal swabs combined, but for the purpose of this review, it was categorized as nasopharyngeal swabs. 5 Nasal swabs were reported in one study, 6 feces, 6,7 blood, 6 urine, 6,14,15 nasopharyngeal, 5,13-16 sputum, 5,7,14 rectal swab, 13 oropharyngeal, 16 Regarding the type of clinical specimens, BLF had a positivity rate of 91.8% followed by rectal swab (87.8%) then sputum specimens (68.1%). Nasopharyngeal swab which is commonly and widely used 1 had a positive detection rate of 45.5%. A low detection rate was observed in oropharyngeal swab (7.6%) with zero detection from urine samples.

There was low (1.0%) detection of SARS-CoV-2 in the blood sample, but 

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan

Smoking upregulates angiotensin-converting enzyme-2 Receptor: a potential adhesion site for novel coronavirus SARS-CoV-2

Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in

Detection of SARS-CoV-2 in different types of clinical specimens

Sputum and feces after conversion of pharyngeal samples in patients with COVID-19

Surveillance G Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases

Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study

Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: elaboration and explanation

An evidence-based practice guideline for the peer review of electronic search strategies

Scopus or Google Scholar-which is the best search engine for an effective literature research in laser medicine?

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of family cluster

Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau

Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Xiong

Meta-Analyst: software for meta-analysis of binary, continuous, and diagnostic data

Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors

Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

The authors declare that there are no conflict of interests.

GMB: conceptualization, data curation, formal analysis, methodology, manuscript drafting. BJN: data curation, formal analysis, methodology, manuscript review, and editing. MVM: formal analysis and manuscript review and editing. AM: methodology and manuscript review and editing.All authors have read and approved the final version of this manuscript.

All relevant data are within the manuscript and its Supporting Information files (Additional Files S1-S3).

George M. Bwire http://orcid.org/0000-0002-4867-7200